Samples collected from a mouth rinse can detect human papillomavirus (HPV) DNA. These easily collected samples might provide important monitoring information for patients with certain head and neck … [Read more...]
EMERGING TESTS
HPV DNA from Oral Rinse Samples May Be Prognostic Marker for Head, Neck Cancer
June 3, 2019
EMERGING TESTS
Improved Accuracy of Point-of-Care HbA1c Tests May Expand Access to Testing
May 28, 2019
The U.S. Food and Drug Administration-cleared POC Afinion HbA1c Dx test (Alere Technologies a subsidiary of Abbott Laboratories) is accurate and precise for diagnosing diabetes using both fingerstick … [Read more...]
EMERGING TESTS
Spectroscopy IDs Potential Metabolic Markers to Diagnose Fibromyalgia
May 23, 2019
The identification of metabolic patterns in the blood of patients with fibromyalgia may improve diagnosis and enable discovery of targeted treatments, according to a study published Feb. 15 in the … [Read more...]
EMERGING TESTS
New Point-of Care Paper Test May Improve Diagnosis of Preeclampsia
May 6, 2019
The Congo Red Dot (CRD) Paper Test is a simple, rapid, non-invasive tool that that may improve triage and the accuracy of preeclampsia (PE) diagnosis at the point of care, according to a pilot study … [Read more...]
EMERGING TESTS
Progress Seen With EGFR Testing, But Adoption Still Lagging
April 23, 2019
Incomplete implementation of EGFR testing guidelines remains a problem in the realm of non-small cell lung cancer (NSCLC), according to a study published in the Journal of Global Oncology. The authors … [Read more...]
PRECISION MEDICINE
Can a Blood Test Quantify Pain?
April 15, 2019
A new test could help clinicians objectively measure pain. According to a study published Feb. 12 in Molecular Psychiatry, the identified biomarkers can predict pain severity and future emergency … [Read more...]
PRECISION MEDICINE
Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies
March 15, 2019
Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last 10 years. While whole-exome sequencing (WES) has shown utility … [Read more...]
PRECISION MEDICINE
Donor-Derived, Cell-Free DNA May Predict Lung Transplant Rejection
March 11, 2019
Elevated donor-derived, cell-free DNA (ddcfDNA) in the 3 months post-lung transplant can identify clinically silent allograft injury and predict progression to chronic rejection, according to a … [Read more...]
EMERGING TESTS
Calprotectin May Predict Arthritis Relapse
February 25, 2019
Baseline calprotectin serum levels independently predicted disease relapse in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) taking tumor necrosis factor inhibitors (TNFi) … [Read more...]
EMERGING TESTS
Study Showing PGx Testing Improves Depression Outcomes, Key to Myriad’s Reimbursement Strategy
February 18, 2019
Pharmacogenomic testing (PGx) provides clinically meaningful improvement in response and remission rates for difficult-to-treat depression patients over standard of care, according to a study … [Read more...]
